India - Healthcare, Regulatory and Reimbursement Landscape

India - Healthcare, Regulatory and Reimbursement Landscape

  • February 2021 •
  • 179 pages •
  • Report ID: 6028640 •
  • Format: PDF
India - Healthcare, Regulatory and Reimbursement Landscape

The analyst has released its latest report: “India - Healthcare, Regulatory and Reimbursement Landscape”.The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in India.

It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure.Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.

It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by team of industry experts.

The Indian pharmaceutical market was worth $13.56B in 2013, which increased to $20.03B in 2019 at a CAGR of 6.57%. The market value is expected to increase further to $29.34B by 2025. In 2020, India was ranked third globally for drug production by volume and 14th by value. It is the largest provider of generic medicines, with a 20% share of global supply by volume. In terms of vaccine production, India meets 62% of the global demand. The growth of the pharmaceutical market is attributed to the innovation and R&D, medical tourism, increased pharmaceutical export, infrastructure development, strong drug manufacturing, and strong domestic demand.

The report provides information on the healthcare, regulatory, and reimbursement landscape in India, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analysis of the major players in the pharmaceutical market: Sun Pharma, Aurobindo Pharma, Dr. Reddy’s Laboratories, GSK, and Novartis
- Profiles and SWOT analysis of the major players in the medical device market: GE Healthcare, Siemens Healthineers, DePuy Synthes, Olympus, and Poly Medicure
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the India healthcare market

Reasons to Buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving India’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact India’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

We are very sorry, but an error occurred.
Please contact if the problem remains.